Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v2-FR Version v2-FR
Language French French
Date Updated 2021-11-23 2021-11-23
Drug Identification Number 02413493 02413493
Brand name MYLAN-RISPERIDONE ODT MYLAN-RISPERIDONE ODT
Common or Proper name RISPERIDONE RISPERIDONE
Company Name MYLAN PHARMACEUTICALS ULC MYLAN PHARMACEUTICALS ULC
Ingredients RISPERIDONE RISPERIDONE
Strength(s) 1MG 1MG
Dosage form(s) TABLET (ORALLY DISINTEGRATING) TABLET (ORALLY DISINTEGRATING)
Route of administration ORAL ORAL
Packaging size 100BT 100BT
ATC code N05AX N05AX
ATC description ANTIPSYCHOTICS ANTIPSYCHOTICS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date
Actual discontinuation date 2021-11-15 2021-11-15
Remaining supply date 2021-11-15 2021-11-15
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Information on remaining supply
Company comments Discontinued in shortage ID 206. Last lot 3073104 exp 2017-10-31 Discontinued in shortage ID 206. Last lot 3073104 exp 2017-10-31
Health Canada comments